Combination therapy for treating myelodysplastic syndrome and acute myelogenous leukemia

Provided herein are methods, kits, and compositions that can be used to treat hematopoietic disorders using an anti-CD47 agent, such as an antibody, and a hypomethylating agent, such as azacitidine. 本文提供了可以用于使用抗CD47药剂诸如抗体和低甲基化剂诸如阿扎胞苷治疗造血障碍的方法、试剂盒和组合物。...

Full description

Saved in:
Bibliographic Details
Main Authors TRAN KHANH, MAJETI RAVINDRA, CAO YI, MOTT ROBERT L, M. P. ZHAO, TAKIMOTO CHRIS H M
Format Patent
LanguageChinese
English
Published 27.05.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods, kits, and compositions that can be used to treat hematopoietic disorders using an anti-CD47 agent, such as an antibody, and a hypomethylating agent, such as azacitidine. 本文提供了可以用于使用抗CD47药剂诸如抗体和低甲基化剂诸如阿扎胞苷治疗造血障碍的方法、试剂盒和组合物。
Bibliography:Application Number: CN202080072932